IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.564
NA - Nord America 2.385
AS - Asia 665
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 5.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.381
IE - Irlanda 811
SE - Svezia 585
IT - Italia 541
CN - Cina 325
SG - Singapore 268
DE - Germania 101
PL - Polonia 94
UA - Ucraina 92
FI - Finlandia 90
AT - Austria 67
GB - Regno Unito 66
IN - India 52
FR - Francia 49
BE - Belgio 27
RU - Federazione Russa 14
NL - Olanda 10
VN - Vietnam 10
CZ - Repubblica Ceca 7
NG - Nigeria 4
SC - Seychelles 4
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
ID - Indonesia 3
LV - Lettonia 3
ZA - Sudafrica 3
CA - Canada 2
KR - Corea 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
JP - Giappone 1
MA - Marocco 1
MD - Moldavia 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 5.637
Salva come PNG Salva come JPEG
Città #
Dublin 811
Chandler 551
Nyköping 438
Jacksonville 229
Messina 229
Singapore 213
Beijing 179
Ashburn 172
Princeton 128
Medford 115
Warsaw 94
Des Moines 91
Dearborn 90
Cambridge 82
Ann Arbor 71
Vienna 67
Boardman 39
Lancaster 33
Jinan 30
San Mateo 30
Brussels 23
Hyderabad 22
Aversa 20
Wilmington 18
Pune 15
Rome 15
Shenyang 14
Augusta 13
Woodbridge 13
Los Angeles 12
Montpellier 12
Taizhou 11
Dong Ket 10
Haikou 10
Nanjing 10
Zhengzhou 10
Hebei 9
Bari 8
Catania 8
New York 8
Brno 7
Francofonte 7
Helsinki 7
Houston 7
Santa Clara 7
Siderno 7
Berlin 6
Borghetto Santo Spirito 6
Caltagirone 6
Francavilla di Sicilia 6
Nanchang 6
Seattle 6
Tianjin 6
Milan 5
Mumbai 5
New Delhi 5
Ningbo 5
Norwalk 5
Riposto 5
Riva 5
Southampton 5
Amsterdam 4
Fuzhou 4
Hangzhou 4
Jiaxing 4
Trecastagni 4
Cape Town 3
Fontaniva 3
Irpin 3
Jakarta 3
Lentini 3
Leonforte 3
Munich 3
Nocera Terinese 3
Patti 3
Piazza Armerina 3
Rosarno 3
Shenzhen 3
Washington 3
Avola 2
Brussel 2
Cedar Knolls 2
Clearwater 2
Dongguan 2
Elk Grove Village 2
Enna 2
Falls Church 2
Ferrara 2
Fremont 2
Groningen 2
Guangzhou 2
Hefei 2
Katsina 2
Kemerovo 2
Kunming 2
Lagos 2
Lanzhou 2
Lappeenranta 2
Mazzarino 2
Milazzo 2
Totale 4.178
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 109
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 104
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 88
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 87
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 86
Role of the microbiota in hematologic malignancies. 86
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 81
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 76
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 76
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 76
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 74
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 71
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 71
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 71
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 70
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 70
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 69
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 69
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 69
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 69
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 68
Design and synthesis of novel isoxazole-based HDAC inhibitors 66
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 66
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 64
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 64
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 63
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 62
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 61
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 61
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 60
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 58
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 58
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 58
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 58
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 57
Falcipain-2 inhibitors 57
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 57
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 56
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 56
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 56
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 55
Evaluation of curcumin irreversibility 55
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 55
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 54
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 54
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 54
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 52
Development of novel amides as non covalent inhibitors of immunoproteasome 52
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 52
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 51
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 50
Glutamate Binding-Site Ligands of NMDA Receptors 50
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 50
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 48
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 48
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 48
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 48
Recent Advances in Nanotherapeutics for Multiple Myeloma 48
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 47
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 47
Novel 2H-Isoquinolin-3-ones Falcipain-2 Inhibitors as Antimalarial Agents 46
Novel peptidomimetic cysteine protease inhibitors as antimalarial agents 46
Development of peptidomimetic boronates as proteasome inhibitors 46
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 46
Effect of mammalian SERCA inhibitors on Plasmodium falciparum growth in vitro 45
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 45
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 45
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 43
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 43
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 42
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 42
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 41
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 41
null 41
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 41
NMR conformational analysis in solution of a potent class of cysteine proteases inhibitors 40
Composti antitumorali 40
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 40
Development of peptidomimetic boronates as proteasome inhibitors 39
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 38
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 37
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 37
Discovery of novel reversible proteasome inhibitors by a multistep docking based virtual screening (VS) 37
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 36
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 36
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 36
Synthesis and pharmacological evaluation of α4β2 nicotinic ligands with a 3-fluoropyrrolidine nucleus 36
Development of novel pseudopeptides targeting the 20S proteasome as anticancer agents 36
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 35
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 35
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 35
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 32
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 32
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 32
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 31
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 31
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 30
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 30
Progettazione e sintesi di nuovi inibitori del proteasoma quali potenti agenti antitumorali 29
Development of Rhodesain Inhibitors with a 3-Bromoisoxazoline Warhead 28
Totale 5.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020533 0 0 0 0 4 95 73 49 11 156 114 31
2020/2021755 64 24 120 34 99 85 23 55 81 107 29 34
2021/2022774 11 104 6 48 14 6 65 25 7 53 134 301
2022/20232.305 184 204 104 180 141 231 36 149 971 4 78 23
2023/2024598 69 72 41 145 55 48 6 8 5 62 37 50
2024/2025354 41 23 44 158 88 0 0 0 0 0 0 0
Totale 6.132